Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial

被引:39
|
作者
Leite de Fornasari, Margareth Lage [1 ]
dos Santos Sens, Yvoty Alves [2 ]
机构
[1] Sch Med Sci, Post Graduat Hlth Sci, Div Santa Casa Sao Paulo, Sao Paulo, Brazil
[2] Nephron Grp, Substitut Renal Therapy, Sao Paulo, SP, Brazil
关键词
CHRONIC KIDNEY-DISEASE; DIETARY-PROTEIN INTAKE; HEMODIALYSIS-PATIENTS; HEALTH IMPACT; HYPERPHOSPHATEMIA; MORTALITY; METABOLISM; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I
10.1053/j.jrn.2016.08.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The purpose of the study was to verify the effects of replacing phosphorus-containing food additives with foods without additives on phosphatemia in end-stage renal disease (ESRD) patients. Design: Randomized clinical trial. Setting: Adult patients on hemodialysis for >= 6 months at a single center. Subjects: A total of 134 patients with phosphorus levels of. 5.5 mg/dL were included and were randomized into an intervention group (n 5 67) and a control group (n 5 67). Intervention: The IG received individual orientation to replace processed foods that have phosphorus additives with foods of similar nutritional value without these additives. The CG received only the nutritional orientation given before the study. Clinical laboratory data, nutritional status, energy and protein intake, and normalized protein nitrogen appearance (nPNA) were evaluated at the beginning of the study and after 90 days. Results: There was no initial difference between the groups in terms of serum phosphorus levels, nutritional status, and energy intake. After 3 months, there was a decline in phosphorus levels in the IG (from 7.2 +/- 1.4 to 5.0 +/- 1.3 mg/dL, P < .001), but there was no significant difference in the CG (from 7.1 +/- 1.2 to 6.7 +/- 1.2 mg/dL, P =.65). In the IG, 69.7% of the patients reached the serum phosphorus target of <= 5.5 mg/dL; however, only 18.5% of the CG subjects reached this level (P,.001). Conclusion: At the end, there was no difference between the two groups in terms of nutritional status, energy intake, protein intake, and nPNA. The replacing phosphorus-containing food additives with foods without additives reduced serum phosphorus without interfering in the nutritional status of ESRD patients. (C) 2016 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [1] Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial
    Sullivan, Catherine
    Sayre, Srilekha S.
    Leon, Janeen B.
    Machekano, Rhoderick
    Love, Thomas E.
    Porter, David
    Marbury, Marquisha
    Sehgal, Ashwini R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (06): : 629 - 635
  • [2] Phosphorus-containing food additives and the accuracy of nutrient databases: Implications for renal patients
    Sullivan, Catherine M.
    Leon, Janeen B.
    Sehgal, Ashwini R.
    JOURNAL OF RENAL NUTRITION, 2007, 17 (05) : 350 - 354
  • [3] Empowerment of patients with end-stage renal disease - a randomized controlled trial
    Tsay, SL
    Hung, LO
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2004, 41 (01) : 59 - 65
  • [4] Acupressure and fatigue in patients with end-stage renal disease - a randomized controlled trial
    Tsay, SL
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2004, 41 (01) : 99 - 106
  • [5] Are There Fast-Food Choices for End-Stage Renal Disease Patients? A Look at Phosphorus and Potassium Content in Common Fast Foods
    Arquette, Christina
    JOURNAL OF RENAL NUTRITION, 2014, 24 (03) : E19 - E21
  • [6] Acupressure and quality of sleep in patients with end-stage renal disease - a randomized controlled trial
    Tsay, SL
    Chen, ML
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2003, 40 (01) : 1 - 7
  • [7] The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure - A randomized, controlled trial
    Tepel, M
    van der Giet, M
    Statz, M
    Jankowski, J
    Zidek, W
    CIRCULATION, 2003, 107 (07) : 992 - 995
  • [8] B-VITAMINS AND TOTAL MORTALITY AND CARDIOVASCULAR DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE. A RANDOMIZED CLINICAL TRIAL
    Dierkes, Jutta
    Heinz, Judith
    Domroese, Ute
    Westphal, Sabine
    Kropf, Siegfried
    Neumann, Klaus Hinrich
    Luley, Claus
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 83 - 83
  • [9] Clinical findings in patients with mitral annulus calcification: Comparison of patients with and without end-stage renal disease (ESRD)
    Wall, BM
    Aslam, N
    D'Cruz, I
    Bittrick, J
    Mangold, T
    Acchiardo, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 467A - 467A
  • [10] Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease
    Yamanouchi, Masayuki
    Skupien, Jan
    Niewczas, Monika A.
    Smiles, Adam M.
    Doria, Alessandro
    Stanton, Robert C.
    Galecki, Andrzej T.
    Duffin, Kevin L.
    Pullen, Nick
    Breyer, Matthew D.
    Bonventre, Joseph V.
    Warram, James H.
    Krolewski, Andrzej S.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 258 - 266